Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 182 M157 M160 M159 M178 M185 M 682 M Research & development 67 M67 M63 M58 M60 M65 M 246 M Operating income 412 M379 M264 M143 M276 M414 M 1.1 B Non-Operating Income, Total -8 M-49 M-3 M-24 M-13 M-14 M -54 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses -8 M-49 M-3 M-24 M-13 M-14 M -54 M Unusual income/expense —————— — Pretax income 253 M169 M134 M12 M136 M256 M 538 M Equity in earnings —————— — Taxes 70 M29 M87 M-93 M29 M72 M 95 M Non-controlling/minority interest 1 M00001 M 1 M After tax other income/expense —————— — Net income before discontinued operations 182 M140 M47 M105 M107 M183 M 442 M Discontinued operations —————— — Net income 182 M140 M47 M105 M107 M183 M 442 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 182 M140 M47 M105 M107 M183 M 442 M Basic earnings per share (Basic EPS) 1.581.220.410.930.931.6 3.87 Diluted earnings per share (Diluted EPS) 1.571.20.40.930.931.59 3.85 Average basic shares outstanding 115.2 M115 M114.4 M114.7 M114.2 M114.3 M — Diluted shares outstanding 116.5 M116.2 M115.4 M115.6 M115 M115.3 M — EBITDA 538 M506 M393 M274 M407 M546 M 1.62 B EBIT 412 M379 M264 M143 M276 M414 M 1.1 B Cost of revenue 1.72 B1.78 B1.77 B1.64 B1.75 B1.95 B 7.1 B Other cost of goods sold —————— — Depreciation & amortization (cash flow) 126 M127 M129 M131 M131 M132 M 523 M